Aktie 853815 BAXTER INTERNATIONAL INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Baxter International Inc. Berne S.E.

Aktien

853815

US0718131099

BAX

Verzögert Berne S.E.
Andere Börsenplätze
 18:00:00 06.04.2023 		% 5 Tage % 1. Jan.
38.11 CHF +3.50% Intraday Chart für Baxter International Inc. -.--% -.--%
20.06. Zimmer Biomet Holdings, Inc. ernennt Devdatt Kurdikar zum Mitglied des Verwaltungsrats CI
12.06. Transcript : Baxter International Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 08:40 AM

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Zimmer Biomet Holdings, Inc. Appoints Devdatt Kurdikar to its Board of Directors
Fitch Affirms and Withdraws Baxter's Ratings
Baxter to Present at Goldman Sachs 45th Annual Global Healthcare Conference
EE.UU. - Valores a seguir en Wall Street (actualizado)
New Cohort Study Data Shows Baxter's Expanded Hemodialysis, Known as HDx Therapy is associated with approximately 25% Lower Mortality Rate for up to Four Years
New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
Baxter International Inc. Announces New Data Showing Expanded Hemodialysis, Known as HDX Therapy
Baxter to Present at Jefferies 2024 Global Healthcare Conference
Baxter Announces Mission and Logo for Proposed Kidney Care Company Vantive
Baxter International's Clinolipid Injection Approved for Expanded Use in US
Baxter Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric Indication
Baxter International Inc. Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric Indication
Declaration of Voting Results by Baxter International Inc
Baxter to Present at Bank of America 2024 Health Care Conference
Baxter International Keeps Quarterly Cash Dividend at $0.29 a Share, Payable July 1 to Shareholders as of May 31
Baxter Declares Quarterly Dividend
Baxter International Inc. Declares Quarterly Dividend, Payable on July 1, 2024
Baxter International Q1 Adjusted Earnings, Net Sales Gain; Boosts 2024 Adjusted Profit Guidance
Baxter International : Q1 2024 Financial Schedules
(BAX) BAXTER INTERNATIONAL Forecasts Q2 Adjusted EPS Range $0.65 - $0.67
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 853815 Aktie
  4. 853815 Aktie
  5. Nachrichten Baxter International Inc.
  6. Andere Sprachen